yttrium radioisotopes has been researched along with Angiogenesis, Pathologic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsultan, AA; Barentsz, MW; Koopman, M; Lam, MGEH; Rosenbaum, CENM; Smits, MLJ | 1 |
| Carpizo, DR; Gendel, VM; Gensure, RH; Greene, SJ; Jabbour, SK; Moore, DF; Nosher, JL; Yu, X | 1 |
| Andreoli, JM; Baker, T; Gabr, A; Hickey, R; Kallini, JR; Kircher, S; Kulik, L; Lewandowski, RJ; Salem, R | 1 |
| Antoch, G; Gerken, G; Haberkorn, U; Hamami, M; Hilgard, P; Müller, S; Sauerwein, WS | 1 |
| Ibrahim, S; Lewandowski, RJ; Omary, RA; Ryu, RK; Salem, R; Sato, KT; Takehana, C | 1 |
| Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK | 1 |
| Anne, PR; Brown, DB; Doyle, LA; Eschelman, DJ; Frangos, A; Gonsalves, CF; McCann, JW; Petroziello, MF; Sato, T | 1 |
| Antoch, G; Bockisch, A; Ertle, J; Gerken, G; Hamami, M; Heusner, TA; Lauenstein, TC; Schlaak, JF | 1 |
| Buczkowski, A; Ho, S; Klass, D; Kritzinger, J; Lim, H; Liu, D; Yoshida, E | 1 |
| Han, KH; Kim, DY | 1 |
| Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
| Ghandehari, H; Line, BR; Mitra, A; Nan, A; Papadimitriou, JC | 1 |
| Brazier, OJ; Fallon, TJ; Joplin, GF; Kohner, EM; Sandler, L; Sharp, PS | 1 |
3 review(s) available for yttrium radioisotopes and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Angiogenesis in
Topics: Colorectal Neoplasms; Humans; Liver Neoplasms; Neovascularization, Pathologic; Yttrium Radioisotopes | 2019 |
[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Topics: Algorithms; Brachytherapy; Carcinoma, Hepatocellular; Diagnostic Imaging; Embolization, Therapeutic; Humans; Iodine Radioisotopes; Iodized Oil; Liver Function Tests; Liver Neoplasms; Microspheres; Neovascularization, Pathologic; Radiation Tolerance; Radioisotopes; Radiotherapy Dosage; Rhenium; Yttrium Radioisotopes | 2009 |
Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Emulsions; Equipment Design; Ethiodized Oil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Neovascularization, Pathologic; Radiography, Interventional; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
2 trial(s) available for yttrium radioisotopes and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib.
Topics: Aged; Angiogenesis Inhibitors; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chicago; Down-Regulation; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pilot Projects; Platelet-Derived Growth Factor; Prospective Studies; Radiopharmaceuticals; Sorafenib; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Side-branch embolization before 90Y radioembolization: rate of recanalization and new collateral development.
Topics: Adult; Aged; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Radiography; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2011 |
8 other study(ies) available for yttrium radioisotopes and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.
Topics: Adult; Aged; Aged, 80 and over; Angiogenic Proteins; Biomarkers, Tumor; Carcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Cytokines; Embolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neovascularization, Pathologic; Pilot Projects; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Resins, Synthetic; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.
Topics: Angiography, Digital Subtraction; Contrast Media; Female; Humans; Illinois; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Angiography; Male; Microspheres; Middle Aged; Neovascularization, Pathologic; Patient Selection; Radiation Dosage; Radiography, Interventional; Retrospective Studies; Risk Assessment; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2009 |
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Colorectal Neoplasms; Female; Humans; Immunoconjugates; Isothiocyanates; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radioimmunoassay; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Yttrium Radioisotopes | 2011 |
Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Collateral Circulation; Colorectal Neoplasms; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Neovascularization, Pathologic; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Sorafenib; Yttrium Radioisotopes | 2012 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy.
Topics: Animals; Drug Carriers; Humans; Male; Metabolic Clearance Rate; Methacrylates; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Organ Specificity; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy; Technetium; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes | 2006 |
Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.
Topics: Adult; Blood Glucose; Brachytherapy; Diabetic Retinopathy; Eye; Female; Follow-Up Studies; Hormones; Humans; Kidney; Male; Neovascularization, Pathologic; Pituitary Gland; Visual Acuity; Yttrium Radioisotopes | 1987 |